Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Mahsa Gilanipoor
Risperidone vs Olanzapine in Treatment of Schizophrenia: A Double Blind Clinical Trial
MOJ Addiction Medicine & Therapy
Related publications
Effects of Olanzapine, Risperidone and Haloperidol on Prepulse Inhibition in Schizophrenia Patients: A Double-Blind, Randomized Controlled Trial
Schizophrenia Research
Psychiatry
Mental Health
Biological Psychiatry
Efficacy and Tolerability of Olanzapine, Quetiapine, and Risperidone in the Treatment of Early Psychosis: A Randomized, Double-Blind 52-Week Comparison
American Journal of Psychiatry
Psychiatry
Mental Health
A Randomized Double Blind Placebo Controlled Clinical Trial of N-Acetylcysteine Added to Risperidone for Treating Autistic Disorders
BMC Psychiatry
Psychiatry
Mental Health
A Double-Blind, Placebo-Controlled Dose-Response Comparison of Intramuscular Olanzapine and Haloperidol in the Treatment of Acute Agitation in Schizophrenia
Archives of General Psychiatry
Blonanserin vs Risperidone in Japanese Patients With Schizophrenia: A Post Hoc Analysis of a Phase 3, 8‐week, Multicenter, Double‐blind, Randomized Controlled Study
Neuropsychopharmacology Reports
Psychiatry
Clinical Psychology
Mental Health
Pharmacology
Cost/Effectiveness of Aripiprazole vs. Olanzapine in the Long-Term Treatment of Schizophrenia
Srpski Arhiv Za Celokupno Lekarstvo
Medicine
Double-Blind Randomized Trial of Risperidone Versus Divalproex in Pediatric Bipolar Disorder: fMRI Outcomes
Psychiatry Research - Neuroimaging
Mental Health
Radiology
Nuclear Medicine
Imaging
Psychiatry
Neuroscience
Aripiprazole Versus Quetiapine in Treatment-Resistant Obsessive–compulsive Disorder: A Double-Blind Clinical Trial
Therapeutic Advances in Psychopharmacology
Randomized, Double-Blind Trial of Olanzapine Versus Placebo in Patients Prodromally Symptomatic for Psychosis
American Journal of Psychiatry
Psychiatry
Mental Health
